Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 0 | 0 | 0 | 0 | 3,114 |
| Gross Profit | N/A | N/A | N/A | N/A | 3,114 |
| Operating Expenses | 7,756 | 7,684 | 7,784 | 7,562 | 8,725 |
| Operating Income | -7,756 | -7,684 | -7,784 | -7,562 | -5,611 |
| Other Income | 9,583 | 2,521 | -25 | 35,423 | -2,264 |
| Pre-tax Income | 1,827 | -5,163 | -7,809 | 27,861 | -7,875 |
| Net Income Continuous | 1,827 | -5,163 | -7,809 | 27,861 | -7,875 |
| Net Income Discontinuous | 946 | 521 | 165 | 149 | 178 |
| Net Income | $2,773 | $-4,642 | $-7,644 | $28,010 | $-7,697 |
| EPS Basic Total Ops | 12,594.20 | -30,645.46 | -47,883.54 | 178,126.80 | -49,479.66 |
| EPS Basic Continuous Ops | 8,297.10 | -33,668.70 | -48,841.21 | 177,169.10 | -50,756.56 |
| EPS Basic Discontinuous Ops | 4,295.24 | 3,208.18 | 1,034.61 | 946.93 | 1,150.94 |
| EPS Diluted Total Ops | 12,594.20 | -30,645.46 | -47,883.54 | 178,126.80 | -49,479.66 |
| EPS Diluted Continuous Ops | 8,297.10 | -33,694.51 | -48,841.21 | 177,169.10 | -50,756.56 |
| EPS Diluted Discontinuous Ops | 4,295.24 | 3,204.45 | 1,034.61 | 946.93 | 1,150.94 |
| EBITDA(a) | $-7,578 | $-7,523 | $-7,562 | $-7,286 | $-5,369 |